Skip to main content

AMA Journal of Ethics®

Illuminating the Art of Medicine

Main navigation

  • Home
  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • For Authors
  • Call for Papers
  • Editorial Fellows
  • Art Institute of Chicago
  • Conley Winners
  • Trending Topic-Abortion

Search Results

Search

  • (-) State of the Art and Science (1)
  • CME (2)
  • Medical Education (1)
  • Policy Forum (1)
  • (-) Diagnosis/Errors (1)
  • Ethics/Practice (3)
  • Genetics/Genetic testing (3)
  • Evidence-based practice/Effectiveness (2)
  • Decision making/Patient and family centered care (1)
  • Disability/Defining disability (1)
  • Disability/Mental illness (1)
  • Genetics/Enhancement (1)
  • Genetics/Genetic counseling (1)
  • Goals of health care/Enhancement (1)
  • Mental health/Disability (1)
  • Professionalism/Professional governance (1)
  • Reproductive health/Contraception (1)
  • Reproductive health/In vitro fertilization (1)
  • Reproductive health/Preimplantation genetic diagnosis (1)
  • Interpersonal and Communication Skills (1)
  • Medical Knowledge (1)
  • Patient Care (1)
  • Systems-Based Practice (1)
  • Obstetrics and Gynecology (1)
State of the Art and Science
Oct 2019

Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients?

Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE
Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients.
AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858.

AMA Journal of Ethics®

Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • FAQ
  • Contact
American Medical Association
Copyright 2023 American Medical Association. All Rights Reserved. ISSN 2376-6980